|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to New York Times Health News Archives
New York Times Health News: 12-19-2004
Scott and Jill Stimell faced an agonizing choice: they could watch their child die, or pursue a drastic and painful treatment.
The story of COX-2 drugs is an example of how difficult it is for the F.D.A. to monitor the safety of drugs after they have been approved for the market.
Nearly three-fourths of Americans middle age and older support legalizing marijuana for medical use, according to a poll taken for AARP.
Families of hundreds of ill children say the majority of attention is being focused on the fate of nurses blamed for the infections.
The $500 billion drug industry is stumbling badly in its core business of finding new medicines, while aggressively marketing existing drugs.
The panel said the shots should be available to all people 50 and older and people who come in close contact with those at high risk of the viral illness.
|
|
